StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
499
This month
6
This year
34
Publishing Date
2024 - 03 - 28
3
2023 - 07 - 24
4
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 08 - 15
3
2022 - 07 - 04
2
2022 - 06 - 03
3
2022 - 05 - 24
2
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 24
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 18
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
2
2021 - 06 - 21
3
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
2
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
3
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Sector
Communications
8
Distribution services
1
Electronic technology
3
Finance
7
Health services
3
Health technology
499
Manufacturing
15
N/a
4
Process industries
5
Professional, scientific, and technical services
8
Retail trade
1
Technology services
4
Tags
Agreement
12
Alliances
22
Antiviral
12
Application
9
Approval
16
Bioscience
10
Biotech
9
Biotech-bay
48
Biotech-beach
11
Breast cancer
22
Cancer
59
Chmp
11
Clinical-trials-phase-iii
14
Collaboration
23
Conference
14
Covid
14
Covid-19
16
Disease
20
Drug
25
Earnings
17
Events
20
Fda
21
Fda-approvals
10
Financial
23
Financial results
20
Genetown
11
Global
35
Growth
10
Health
13
Hepatitis
19
Hiv
41
Leukemia
10
License
13
Liver
11
Market
48
Money
9
N/a
225
People
19
Pharma
12
Pharmaceutical
10
Phase 2
9
Phase 3
9
Positive
13
Potential
10
Pre-clinical
9
Preclinical
10
Report
19
Research
54
Results
51
Sciences
29
Study
11
T-cell
32
Technology
9
Therapeutics
42
Therapy
52
Treatment
50
Trial
23
Trodelvy
15
Year
9
Yescarta
14
Entities
Aadi biosciences inc
3
Abbott laboratories
12
Abbvie inc.
41
Adaptimmune therapeutics plc
3
Allovir, inc.
3
Alnylam pharmaceuticals, inc.
6
Amgen inc.
35
Arcellx, inc.
7
Arcus biosciences, inc.
3
Assembly biosciences, inc.
6
Astellas pharma inc
3
Astrazeneca plc
10
Baxter international inc.
3
Biocryst pharmaceuticals, inc.
13
Biogen inc.
6
Biomarin pharmaceutical inc.
4
Biontech se
3
Bluebird bio, inc.
4
Bristol-myers squibb company
45
Calliditas therapeutics ab
3
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eli lilly and company
35
Exelixis, inc.
3
Galapagos nv
20
Genmab a/s
4
Gilead sciences, inc.
499
Glaxosmithkline plc
24
Hookipa pharma inc.
16
Humanigen, inc.
3
Immunogen, inc.
4
Intellia therapeutics, inc.
3
Johnson & johnson
43
Jounce therapeutics, inc.
25
Macrogenics, inc.
5
Merck & company, inc.
5
Morphosys ag
4
Novartis ag
28
Novo nordisk a/s
10
Nrx pharmaceuticals inc
3
Nurix therapeutics, inc.
4
Omeros corporation
14
Orange
8
Otonomy, inc.
13
Pfizer, inc.
27
Regeneron pharmaceuticals, inc.
11
Sangamo therapeutics, inc.
4
Sanofi
64
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
6
Veru inc.
4
Viatris inc.
5
Vir biotechnology, inc.
6
Xeris pharmaceuticals, inc.
11
Xilio therapeutics inc
4
Symbols
AAPL
1192
ABB
1422
ABBV
1022
ABLZF
1161
ABT
1784
ACN
600
AMGN
741
ARVL
4284
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
895
DHR
785
ERIC
1607
F
641
FNCTF
7170
FRBA
595
GE
915
GLAXF
657
GOOG
1271
GOOGL
1270
GSK
883
HON
1777
HUBS
1400
IBM
654
INTC
954
IT
590
JNJ
4571
LLY
1708
LTUM
970
LYV
717
MDT
1284
MMM
938
MS
4277
MSFT
1199
MT
588
NOC
588
NOK
898
NOKBF
972
NVO
631
NVS
1241
NVSEF
1031
ORCL
1156
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1126
PPRUY
1127
SAP
1473
SAPGF
1227
SNOW
794
SNY
4532
SNYNF
3590
TEVJF
630
TMO
1621
VZ
1211
XYF
674
Exchanges
Amex
2
Nasdaq
499
Nyse
116
Crawled Date
2024 - 03 - 28
3
2023 - 12 - 12
3
2023 - 07 - 24
3
2023 - 06 - 01
3
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 06 - 03
3
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 31
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 19
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 12 - 15
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
3
2021 - 06 - 21
2
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
3
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
4
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Crawled Time
00:00
19
00:20
2
01:00
17
02:00
2
03:00
3
04:00
3
04:20
1
06:00
5
07:00
7
08:00
6
09:00
7
09:52
1
10:00
7
10:51
1
11:00
33
11:33
3
12:00
41
12:03
1
12:06
1
12:15
12
12:20
6
12:30
1
12:34
1
13:00
44
13:01
1
13:07
1
13:15
5
13:17
1
13:20
19
13:27
1
13:30
3
13:52
1
14:00
39
14:01
1
14:03
2
14:15
3
14:20
6
14:30
10
15:00
22
15:15
2
15:17
1
15:20
3
15:30
4
15:49
1
15:56
1
15:59
1
16:00
14
16:20
2
17:00
17
17:43
1
18:00
12
18:11
1
18:32
1
19:00
10
19:47
1
20:00
24
21:00
17
21:03
1
22:00
27
23:00
19
Source
galmedpharma.com
1
investor.assemblybio.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
273
www.fda.gov
19
www.globenewswire.com
80
www.igmbio.com
1
www.nurixtx.com
1
www.prnewswire.com
122
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GILD
save search
Trodelvy® Continues to Show Durable Overall Survival Advantage in Pre-Treated HR+/HER2- Metastatic Breast Cancer
Published:
2023-06-05
(Crawled : 17:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.58%
|
O:
-0.09%
H:
0.27%
C:
-0.13%
trodelvy
advantage
breast
cancer
show
Kite’s Yescarta® CAR T-cell Therapy Demonstrates Significantly Longer Overall Survival Versus Standard of Care as Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma
Published:
2023-06-05
(Crawled : 17:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.58%
|
O:
-0.09%
H:
0.27%
C:
-0.13%
yescarta
t-cell
treatment
care
therapy
ASCO: Gilead and Arcus's Cancer Immunotherapy Combo Faces Scrutiny Over Lower...
Published:
2023-06-03
(Crawled : 00:20)
- biospace.com/
RCUS
4
|
$14.84
-6.49%
0.0%
790K
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
cancer
immunotherapy
Culture Biosciences Establishes Advisory Board of Biotech and Biopharma Executives to Guide the Corporate Strategy and Accelerate Growth
Published:
2023-06-01
(Crawled : 14:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-12.52%
|
O:
0.78%
H:
0.0%
C:
-1.72%
biotech
biopharma
growth
Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA
Published:
2023-06-01
(Crawled : 13:20)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-12.52%
|
O:
0.78%
H:
0.0%
C:
-1.72%
pipeline
cell
growing
therapy
Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published:
2023-05-31
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
21.03%
|
O:
-0.24%
H:
2.1%
C:
2.1%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
21.53%
|
O:
0.0%
H:
0.66%
C:
0.33%
TEVA
|
$13.18
0.69%
0.46%
6.6M
|
Health Technology
|
81.81%
|
O:
0.42%
H:
0.83%
C:
-0.41%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.84%
|
O:
-0.34%
H:
0.32%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
18.9%
|
O:
-0.24%
H:
1.43%
C:
0.84%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-25.11%
|
O:
0.03%
H:
0.41%
C:
0.34%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
17.82%
|
O:
-1.96%
H:
0.0%
C:
-1.35%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
7.07%
|
O:
-0.09%
H:
0.97%
C:
0.89%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-12.52%
|
O:
0.78%
H:
0.0%
C:
-1.72%
report
treatment
global
hiv
therapy
growth
market
Global Pulmonary Arterial Hypertension Market Report 2023: Increasing Awareness and Diagnosis of PAH Bolsters Growth
Published:
2023-05-31
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
21.03%
|
O:
-0.24%
H:
2.1%
C:
2.1%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
18.19%
|
O:
2.39%
H:
0.0%
C:
-0.16%
TEVA
|
$13.18
0.69%
0.46%
6.6M
|
Health Technology
|
81.81%
|
O:
0.42%
H:
0.83%
C:
-0.41%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-3.56%
|
O:
0.79%
H:
0.15%
C:
0.1%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.84%
|
O:
-0.34%
H:
0.32%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
18.9%
|
O:
-0.24%
H:
1.43%
C:
0.84%
UTHR
|
$235.44
1.58%
1.55%
370K
|
Health Technology
|
10.51%
|
O:
0.31%
H:
1.97%
C:
1.46%
KROS
|
$59.42
2.45%
2.39%
400K
|
Health Technology
|
21.19%
|
O:
-0.1%
H:
1.23%
C:
-0.02%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-12.52%
|
O:
0.78%
H:
0.0%
C:
-1.72%
report
global
hypertension
growth
market
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published:
2023-05-26
(Crawled : 15:00)
- prnewswire.com
DAWN
4
|
$14.87
1.78%
1.75%
800K
|
Professional, Scientific, and T...
|
21.14%
|
O:
0.33%
H:
4.21%
C:
3.06%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.07%
|
O:
-0.93%
H:
0.0%
C:
-18.22%
LEGN
|
$48.84
-2.55%
-2.62%
1.4M
|
Health Technology
|
-20.8%
|
O:
0.35%
H:
0.63%
C:
-0.58%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
126.05%
|
O:
0.07%
H:
2.53%
C:
1.23%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.32%
|
O:
0.45%
H:
0.79%
C:
-1.17%
asco
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
Published:
2023-05-26
(Crawled : 09:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.32%
|
O:
0.45%
H:
0.79%
C:
-1.17%
covid-19
veklury
chmp
renal
positive
dialysis
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
Published:
2023-05-22
(Crawled : 20:00)
- globenewswire.com
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.39%
|
O:
-0.03%
H:
1.22%
C:
-0.03%
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-33.76%
|
O:
0.31%
H:
1.23%
C:
-0.45%
immunology
Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023
Published:
2023-05-17
(Crawled : 14:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.06%
|
O:
-0.22%
H:
1.12%
C:
0.85%
asco
cancer
pipeline
care
Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research
Published:
2023-05-15
(Crawled : 11:00)
- prnewswire.com
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.16%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
71.89%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
10.46%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
13.46%
|
O:
0.17%
H:
1.07%
C:
0.19%
QCOM
|
$164.17
-2.62%
-2.69%
8.1M
|
Electronic Technology
|
62.69%
|
O:
0.14%
H:
2.54%
C:
2.43%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.89%
|
O:
-0.13%
H:
0.42%
C:
0.4%
health
research
global
home
market
Size of Microalgae Market to Grow at 4.5% CAGR and Reach $4996.8 Million by 2027: Brandessence Market Research
Published:
2023-05-15
(Crawled : 11:00)
- prnewswire.com
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.16%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
71.89%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
10.46%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
13.46%
|
O:
0.17%
H:
1.07%
C:
0.19%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.89%
|
O:
-0.13%
H:
0.42%
C:
0.4%
CYAN
M
|
$0.33
-0.03%
38K
|
Health Technology
|
-68.57%
|
O:
-4.76%
H:
3.0%
C:
0.0%
reach
research
market
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published:
2023-05-15
(Crawled : 10:00)
- prnewswire.com
UCBJY
|
$63.31
-4.38%
9.4K
|
Manufacturing
|
37.18%
|
O:
1.79%
H:
0.18%
C:
-0.06%
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-19.23%
|
O:
0.61%
H:
0.3%
C:
0.24%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.16%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
71.89%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
10.46%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
13.46%
|
O:
0.17%
H:
1.07%
C:
0.19%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.2%
|
O:
0.38%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.89%
|
O:
-0.13%
H:
0.42%
C:
0.4%
research
global
growth
market
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Published:
2023-05-09
(Crawled : 15:00)
- biospace.com/
FNCTF
|
$11.0354
-20.84%
320
|
Communications
|
-15.11%
|
O:
-0.66%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.35%
|
O:
-0.36%
H:
1.23%
C:
0.63%
lyn-005
schizophrenia
trial
therapeutics
study
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
Published:
2023-05-09
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.35%
|
O:
-0.36%
H:
1.23%
C:
0.63%
pipeline
acquisition
Galapagos announces first quarter 2023 financial results
Published:
2023-05-04
(Crawled : 20:00)
- globenewswire.com
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.28%
|
O:
0.29%
H:
1.37%
C:
1.27%
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-27.19%
|
O:
2.86%
H:
3.14%
C:
2.95%
financial
results
CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)
Published:
2023-05-04
(Crawled : 12:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-15.28%
|
O:
0.2%
H:
0.09%
C:
-1.37%
hepcludex
hepatitis
chmp
authorization
positive
treatment
virus
Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts
Published:
2023-05-03
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-16.32%
|
O:
0.06%
H:
0.51%
C:
-1.29%
hepatitis
Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
Published:
2023-04-26
(Crawled : 00:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-21.36%
|
O:
-1.58%
H:
0.21%
C:
-0.59%
GLPG
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-23.14%
|
O:
-0.08%
H:
2.5%
C:
2.11%
active
program
← Previous
1
2
3
4
5
6
7
8
9
10
…
24
25
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.